Compare CCXI & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCXI | FTH |
|---|---|---|
| Founded | 2025 | N/A |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.4M | 860.0M |
| IPO Year | N/A | 2021 |
| Metric | CCXI | FTH |
|---|---|---|
| Price | $16.68 | $24.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 306.9K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.09 | $17.50 |
| 52 Week High | $19.69 | $37.90 |
| Indicator | CCXI | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 41.68 |
| Support Level | $10.13 | $23.82 |
| Resistance Level | $19.69 | $31.61 |
| Average True Range (ATR) | 1.23 | 2.65 |
| MACD | 0.09 | -0.69 |
| Stochastic Oscillator | 86.45 | 16.06 |
Churchill Capital Corp XI is a blank check company.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.